HCM

NASD HUTCHMED (China) Limited Sponsored ADR

Nov 3, 2026 · 1:08 PM ET DELAYED Market Open

$13.10 ↓ -0.17 (-1.28%) Trading Down from the previous close of $13.27, $0.15 below the day’s high of $13.25

YTD change: -1.73%
vs 20-day SMA: -5.97%
vs 200-day SMA: -0.86%

Price ranges

Previous day

$13.20 $13.46

open $13.23 close $13.27

+$0.04 (+0.30%)

Today

$13.10 $13.25

open $13.25 now $13.10

-$0.15 (-1.13%)

Past week

$13.12 $14.27

from $14.27 now $13.10

-$1.17 (-8.20%)

Past month

$13.12 $14.94

from $14.31 now $13.10

-$1.21 (-8.46%)

This year

$9.77 $16.33

from $13.33 now $13.10

-$0.23 (-1.73%)

Price & Performance

+0.05 (+0.38%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 70.2% away from all-time highs of $43.94
HCM is down 2% since the beginning of the year
HCM is down 14% over the past 12 months
HCM is down 8% over the past 1 month

HCM reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -13.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A

EPS N/A

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $1.1B

Beta -0.41

Balance sheet & scale

Income$18.0K

Revenue$550.5M

Cash$1.4B

Debt$94.5K

Income / Debt 0.19×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $2.3B

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,410.99	-0.46%
JNJ	Johnson & Johnson	$270.56	-0.97%
ABBV	AbbVie, Inc.	$288.84	-2.05%
MRK	Merck & Co., Inc.	$148.36	-0.78%
RHHBY	Roche Holding Ltd Sponsored ADR	$60.67	-0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.